Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet shortage
Current 73 presentations · 11 manufacturers · first FDA posting Oct 12, 2022 · last update Oct 15, 2026
Manufacturers: Alvogen, Aurobindo Pharma USA, Elite Laboratories, Inc., Epic Pharma, LLC, Granules Pharmaceuticals Inc., Lannett Company, Inc., Oryza Pharmaceuticals Inc., Sandoz Inc., SpecGx LLC, Sunrise Pharmaceutical, Inc., Teva Pharmaceuticals USA, Inc.
Stated reasons (per FDA): Demand increase for the drug; Other; Shortage of an active ingredient
More info: FDA Drug Shortages Database · ASHP drug shortages list (search there for this drug)
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5mg (NDC 47781-174-01) | Alvogen | Current Available |
— | Posted Oct 12, 2022 Updated Oct 2, 2026 | |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 10mg (NDC 47781-176-01) | Alvogen | Current Available |
— | Posted Oct 12, 2022 Updated Oct 2, 2026 | |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 15mg (NDC 47781-178-01) | Alvogen | Current Available |
— | Posted Oct 12, 2022 Updated Oct 2, 2026 | |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 20mg (NDC 47781-179-01) | Alvogen | Current Available |
— | Posted Oct 12, 2022 Updated Oct 2, 2026 | |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 30mg (NDC 47781-180-01) | Alvogen | Current Available |
— | Posted Oct 12, 2022 Updated Oct 2, 2026 | |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 13107-068-01) | Aurobindo Pharma USA | Current Unavailable |
Shortage of an active ingredient | Estimated availability: April 2027 | Posted Oct 12, 2022 Updated Oct 2, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg (NDC 13107-069-01) | Aurobindo Pharma USA | Current Unavailable |
Shortage of an active ingredient | Estimated availability: April 2027 | Posted Oct 12, 2022 Updated Oct 2, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 13107-070-01) | Aurobindo Pharma USA | Current Unavailable |
Shortage of an active ingredient | Estimated availability: April 2027 | Posted Oct 12, 2022 Updated Oct 2, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 13107-072-01) | Aurobindo Pharma USA | Current Unavailable |
Shortage of an active ingredient | Estimated availability: April 2027 | Posted Oct 12, 2022 Updated Oct 2, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 13107-073-01) | Aurobindo Pharma USA | Current Unavailable |
Shortage of an active ingredient | Estimated availability: April 2027 | Posted Oct 12, 2022 Updated Oct 2, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 13107-074-01) | Aurobindo Pharma USA | Current Unavailable |
Shortage of an active ingredient | Estimated availability: April 2027 | Posted Oct 12, 2022 Updated Oct 2, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 64850-500-01) | Elite Laboratories, Inc. | Current Available |
— | Posted Oct 12, 2022 Updated Oct 15, 2026 | |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg (NDC 64850-501-01) | Elite Laboratories, Inc. | Current Available |
— | Posted Oct 12, 2022 Updated Oct 15, 2026 | |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 64850-502-01) | Elite Laboratories, Inc. | Current Available |
— | Posted Oct 12, 2022 Updated Oct 15, 2026 | |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.125 mg; 3.125 mg; 3.125 mg; 3.125 mg (NDC 64850-503-01) | Elite Laboratories, Inc. | Current Available |
— | Posted Oct 12, 2022 Updated Oct 15, 2026 | |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 64850-504-01) | Elite Laboratories, Inc. | Current Available |
— | Posted Oct 12, 2022 Updated Oct 15, 2026 | |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 64850-505-01) | Elite Laboratories, Inc. | Current Available |
— | Posted Oct 12, 2022 Updated Oct 15, 2026 | |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 64850-506-01) | Elite Laboratories, Inc. | Current Available |
— | Posted Aug 15, 2023 Updated Oct 15, 2026 | |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 42806-339-01) | Epic Pharma, LLC | Current Limited Availability |
Shortage of an active ingredient | Estimated recovery: TBD | Posted Oct 12, 2022 Updated Oct 5, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 42806-341-01) | Epic Pharma, LLC | Current Limited Availability |
Shortage of an active ingredient | Estimated recovery: TBD | Posted Oct 12, 2022 Updated Oct 5, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 42806-343-01) | Epic Pharma, LLC | Current Limited Availability |
Shortage of an active ingredient | Estimated recovery: TBD | Posted Oct 12, 2022 Updated Oct 5, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 42806-344-01) | Epic Pharma, LLC | Current Limited Availability |
Shortage of an active ingredient | Estimated recovery: TBD | Posted Oct 12, 2022 Updated Oct 5, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 42806-345-01) | Epic Pharma, LLC | Current Limited Availability |
Shortage of an active ingredient | Estimated recovery: TBD | Posted Oct 12, 2022 Updated Oct 5, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 70010-111-01) | Granules Pharmaceuticals Inc. | Current Unavailable |
Shortage of an active ingredient | Estimated recovery: October 2026 | Posted Oct 12, 2022 Updated Oct 13, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg (NDC 70010-112-01) | Granules Pharmaceuticals Inc. | Current Unavailable |
Shortage of an active ingredient | Estimated recovery: October 2026 | Posted Oct 12, 2022 Updated Oct 13, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 70010-113-01) | Granules Pharmaceuticals Inc. | Current Unavailable |
Shortage of an active ingredient | Estimated recovery: October 2026 | Posted Oct 12, 2022 Updated Oct 13, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.125 mg; 3.125 mg; 3.125 mg; 3.125 mg (NDC 70010-114-01) | Granules Pharmaceuticals Inc. | Current Unavailable |
Shortage of an active ingredient | Estimated recovery: October 2026 | Posted Oct 12, 2022 Updated Oct 13, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 70010-115-01) | Granules Pharmaceuticals Inc. | Current Unavailable |
Shortage of an active ingredient | Estimated recovery: October 2026 | Posted Oct 12, 2022 Updated Oct 13, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 70010-116-01) | Granules Pharmaceuticals Inc. | Current Unavailable |
Shortage of an active ingredient | Estimated recovery: October 2026 | Posted Oct 12, 2022 Updated Oct 13, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 70010-117-01) | Granules Pharmaceuticals Inc. | Current Unavailable |
Shortage of an active ingredient | Estimated recovery: October 2026 | Posted Oct 12, 2022 Updated Oct 13, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 0527-0760-37) | Lannett Company, Inc. | Current Available |
— | Posted Oct 12, 2022 Updated Oct 15, 2026 | |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg (NDC 0527-0761-37) | Lannett Company, Inc. | Current Available |
— | Posted Oct 12, 2022 Updated Oct 15, 2026 | |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.125 mg; 3.125 mg; 3.125 mg; 3.125 mg (NDC 0527-0763-37) | Lannett Company, Inc. | Current Available |
— | Posted Oct 12, 2022 Updated Oct 15, 2026 | |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 0527-0764-37) | Lannett Company, Inc. | Current Available |
— | Posted Oct 12, 2022 Updated Oct 15, 2026 | |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 0527-0766-37) | Lannett Company, Inc. | Current Available |
— | Posted Oct 12, 2022 Updated Oct 15, 2026 | |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 0527-1502-37) | Lannett Company, Inc. | Current Available |
— | Posted Oct 12, 2022 Updated Oct 15, 2026 | |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 0527-1505-37) | Lannett Company, Inc. | Current Available |
— | Posted Oct 12, 2022 Updated Oct 15, 2026 | |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 72516-011-01) | Oryza Pharmaceuticals Inc. | Current Unavailable |
Shortage of an active ingredient | Estimated recovery: April 2027 | Posted Oct 12, 2022 Updated Oct 15, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 72516-012-01) | Oryza Pharmaceuticals Inc. | Current Unavailable |
Shortage of an active ingredient | Estimated recovery: April 2027 | Posted Oct 12, 2022 Updated Oct 15, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 72516-013-01) | Oryza Pharmaceuticals Inc. | Current Unavailable |
Shortage of an active ingredient | Estimated recovery: April 2027 | Posted Oct 12, 2022 Updated Oct 15, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 72516-014-01) | Oryza Pharmaceuticals Inc. | Current Unavailable |
Shortage of an active ingredient | Estimated recovery: April 2027 | Posted Oct 12, 2022 Updated Oct 15, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 72516-016-01) | Oryza Pharmaceuticals Inc. | Current Unavailable |
Shortage of an active ingredient | Estimated recovery: April 2027 | Posted Oct 12, 2022 Updated Oct 15, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 0185-0842-01) | Sandoz Inc. | Current Available |
— | Posted Oct 12, 2022 Updated Oct 8, 2026 | |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 0185-0853-01) | Sandoz Inc. | Current Available |
— | Posted Oct 12, 2022 Updated Oct 8, 2026 | |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 0185-2098-01) | Sandoz Inc. | Current Available |
— | Posted Oct 12, 2022 Updated Oct 8, 2026 | |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 0185-2099-01) | Sandoz Inc. | Current Available |
— | Posted Oct 12, 2022 Updated Oct 8, 2026 | |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg (NDC 0406-8884-01) | SpecGx LLC | Current Available |
— | Posted Oct 12, 2022 Updated Aug 20, 2026 | |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 0406-8885-01) | SpecGx LLC | Current Available |
— | Posted Oct 12, 2022 Updated Aug 20, 2026 | |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 0406-8891-01) | SpecGx LLC | Current Limited Availability |
Demand increase for the drug | Estimated recovery: TBD | Posted Oct 12, 2022 Updated Aug 20, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 0406-8892-01) | SpecGx LLC | Current Limited Availability |
Demand increase for the drug | Estimated recovery: TBD | Posted Oct 12, 2022 Updated Aug 20, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 0406-8893-01) | SpecGx LLC | Current Available |
— | Posted Oct 12, 2022 Updated Aug 20, 2026 | |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 0406-8894-01) | SpecGx LLC | Current Limited Availability |
Demand increase for the drug | Estimated recovery: TBD | Posted Oct 12, 2022 Updated Aug 20, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 11534-190-01) | Sunrise Pharmaceutical, Inc. | Current Available |
— | Posted Oct 12, 2022 Updated Oct 15, 2026 | |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg (NDC 11534-191-01) | Sunrise Pharmaceutical, Inc. | Current Available |
— | Posted Oct 12, 2022 Updated Oct 15, 2026 | |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 11534-192-01) | Sunrise Pharmaceutical, Inc. | Current Available |
— | Posted Oct 12, 2022 Updated Oct 15, 2026 | |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.125 mg; 3.125 mg; 3.125 mg; 3.125 mg (NDC 11534-193-01) | Sunrise Pharmaceutical, Inc. | Current Available |
— | Posted Oct 12, 2022 Updated Oct 15, 2026 | |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 11534-194-01) | Sunrise Pharmaceutical, Inc. | Current Available |
— | Posted Oct 12, 2022 Updated Oct 15, 2026 | |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 11534-195-01) | Sunrise Pharmaceutical, Inc. | Current Available |
— | Posted Oct 12, 2022 Updated Oct 15, 2026 | |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 11534-196-01) | Sunrise Pharmaceutical, Inc. | Current Available |
— | Posted Oct 12, 2022 Updated Oct 15, 2026 | |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg (NDC 0555-0775-02) | Teva Pharmaceuticals USA, Inc. | Current Available |
— | Posted Oct 12, 2022 Updated Oct 15, 2026 | |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.125 mg; 3.125 mg; 3.125 mg; 3.125 mg (NDC 0555-0776-02) | Teva Pharmaceuticals USA, Inc. | Current Available |
— | Posted Oct 12, 2022 Updated Oct 15, 2026 | |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 0555-0777-02) | Teva Pharmaceuticals USA, Inc. | Current Limited Availability |
Other | Estimated recovery: October 2026 | Posted Oct 12, 2022 Updated Oct 1, 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 0555-0971-02) | Teva Pharmaceuticals USA, Inc. | Current Available |
— | Posted Oct 12, 2022 Updated Oct 15, 2026 | |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 0555-0972-02) | Teva Pharmaceuticals USA, Inc. | Current Available |
— | Posted Oct 12, 2022 Updated Oct 15, 2026 | |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 0555-0973-02) | Teva Pharmaceuticals USA, Inc. | Current Available |
— | Posted Oct 12, 2022 Updated Oct 15, 2026 | |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 0555-0974-02) | Teva Pharmaceuticals USA, Inc. | Current Available |
— | Posted Oct 12, 2022 Updated Oct 1, 2026 | |
| Adderall, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 57844-105-01) | Teva Pharmaceuticals USA, Inc. | Current Available |
— | Posted Oct 12, 2022 Updated Oct 15, 2026 | |
| Adderall, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 57844-110-01) | Teva Pharmaceuticals USA, Inc. | Current Available |
— | Posted Oct 12, 2022 Updated Oct 15, 2026 | |
| Adderall, Tablet, 3.125 mg; 3.125 mg; 3.125 mg; 3.125 mg (NDC 57844-112-01) | Teva Pharmaceuticals USA, Inc. | Current Unavailable |
Other | Estimated recovery: October 2026 | Posted Oct 12, 2022 Updated Oct 1, 2026 |
| Adderall, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 57844-115-01) | Teva Pharmaceuticals USA, Inc. | Current Available |
— | Posted Oct 12, 2022 Updated Oct 15, 2026 | |
| Adderall, Tablet, 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg (NDC 57844-117-01) | Teva Pharmaceuticals USA, Inc. | Current Available |
— | Posted Oct 12, 2022 Updated Oct 15, 2026 | |
| Adderall, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 57844-120-01) | Teva Pharmaceuticals USA, Inc. | Current Available |
— | Posted Oct 12, 2022 Updated Oct 15, 2026 | |
| Adderall, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 57844-130-01) | Teva Pharmaceuticals USA, Inc. | Current Available |
— | Posted Oct 12, 2022 Updated Oct 15, 2026 |